96 related articles for article (PubMed ID: 16962267)
1. A modified process for preparing cationic polylactide-co-glycolide microparticles with adsorbed DNA.
Singh M; Fang JH; Kazzaz J; Ugozzoli M; Chesko J; Malyala P; Dhaliwal R; Wei R; Hora M; O'Hagan D
Int J Pharm; 2006 Dec; 327(1-2):1-5. PubMed ID: 16962267
[TBL] [Abstract][Full Text] [Related]
2. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells.
Denis-Mize KS; Dupuis M; MacKichan ML; Singh M; Doe B; O'Hagan D; Ulmer JB; Donnelly JJ; McDonald DM; Ott G
Gene Ther; 2000 Dec; 7(24):2105-12. PubMed ID: 11223992
[TBL] [Abstract][Full Text] [Related]
3. The effect of CTAB concentration in cationic PLG microparticles on DNA adsorption and in vivo performance.
Singh M; Ugozzoli M; Briones M; Kazzaz J; Soenawan E; O'Hagan DT
Pharm Res; 2003 Feb; 20(2):247-51. PubMed ID: 12636163
[TBL] [Abstract][Full Text] [Related]
4. Cationic microparticles are a potent delivery system for a HCV DNA vaccine.
O'Hagan DT; Singh M; Dong C; Ugozzoli M; Berger K; Glazer E; Selby M; Wininger M; Ng P; Crawford K; Paliard X; Coates S; Houghton M
Vaccine; 2004 Dec; 23(5):672-80. PubMed ID: 15542189
[TBL] [Abstract][Full Text] [Related]
5. Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination.
Oster CG; Kim N; Grode L; Barbu-Tudoran L; Schaper AK; Kaufmann SH; Kissel T
J Control Release; 2005 May; 104(2):359-77. PubMed ID: 15907586
[TBL] [Abstract][Full Text] [Related]
6. Polylactide-co-glycolide microparticles with surface adsorbed antigens as vaccine delivery systems.
Singh M; Kazzaz J; Ugozzoli M; Malyala P; Chesko J; O'Hagan DT
Curr Drug Deliv; 2006 Jan; 3(1):115-20. PubMed ID: 16472100
[TBL] [Abstract][Full Text] [Related]
7. Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency.
Kazzaz J; Singh M; Ugozzoli M; Chesko J; Soenawan E; O'Hagan DT
J Control Release; 2006 Feb; 110(3):566-73. PubMed ID: 16360956
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticles.
Denis-Mize KS; Dupuis M; Singh M; Woo C; Ugozzoli M; O'Hagan DT; Donnelly JJ; Ott G; McDonald DM
Cell Immunol; 2003 Sep; 225(1):12-20. PubMed ID: 14643300
[TBL] [Abstract][Full Text] [Related]
9. Enhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticles.
Malyala P; O'Hagan DT; Singh M
Adv Drug Deliv Rev; 2009 Mar; 61(3):218-25. PubMed ID: 19168103
[TBL] [Abstract][Full Text] [Related]
10. Spray-drying preparation of microparticles containing cationic PLGA nanospheres as gene carriers for avoiding aggregation of nanospheres.
Takashima Y; Saito R; Nakajima A; Oda M; Kimura A; Kanazawa T; Okada H
Int J Pharm; 2007 Oct; 343(1-2):262-9. PubMed ID: 17628365
[TBL] [Abstract][Full Text] [Related]
11. Polylactide-co-glycolide (PLG) microparticles modify the immune response to DNA vaccination.
Helson R; Olszewska W; Singh M; Megede JZ; Melero JA; O'Hagan D; Openshaw PJ
Vaccine; 2008 Feb; 26(6):753-61. PubMed ID: 18191308
[TBL] [Abstract][Full Text] [Related]
12. Development of hepatitis B oral vaccine using B-cell epitope loaded PLG microparticles.
Rajkannan R; Dhanaraju MD; Gopinath D; Selvaraj D; Jayakumar R
Vaccine; 2006 Jun; 24(24):5149-57. PubMed ID: 16713035
[TBL] [Abstract][Full Text] [Related]
13. Preparation, physiochemical characterization, and oral immunogenicity of Abeta(1-12), Abeta(29-40), and Abeta(1-42) loaded PLG microparticles formulations.
Rajkannan R; Arul V; Malar EJ; Jayakumar R
J Pharm Sci; 2009 Jun; 98(6):2027-39. PubMed ID: 18980172
[TBL] [Abstract][Full Text] [Related]
14. CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine.
Xie H; Gursel I; Ivins BE; Singh M; O'Hagan DT; Ulmer JB; Klinman DM
Infect Immun; 2005 Feb; 73(2):828-33. PubMed ID: 15664922
[TBL] [Abstract][Full Text] [Related]
15. Poly(lactide-co-glycolide) microspheres: a potent oral delivery system to elicit systemic immune response against inactivated rabies virus.
Ramya R; Verma PC; Chaturvedi VK; Gupta PK; Pandey KD; Madhanmohan M; Kannaki TR; Sridevi R; Anukumar B
Vaccine; 2009 Mar; 27(15):2138-43. PubMed ID: 19356617
[TBL] [Abstract][Full Text] [Related]
16. Charged polylactide co-glycolide microparticles as antigen delivery systems.
Singh M; Kazzaz J; Ugozzoli M; Chesko J; O'Hagan DT
Expert Opin Biol Ther; 2004 Apr; 4(4):483-91. PubMed ID: 15102598
[TBL] [Abstract][Full Text] [Related]
17. The potency of the adjuvant, CpG oligos, is enhanced by encapsulation in PLG microparticles.
Malyala P; Chesko J; Ugozzoli M; Goodsell A; Zhou F; Vajdy M; O'Hagan DT; Singh M
J Pharm Sci; 2008 Mar; 97(3):1155-64. PubMed ID: 17683059
[TBL] [Abstract][Full Text] [Related]
18. Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone.
da Silva AA; de Matos JR; Formariz TP; Rossanezi G; Scarpa MV; do Egito ES; de Oliveira AG
Int J Pharm; 2009 Feb; 368(1-2):45-55. PubMed ID: 18992313
[TBL] [Abstract][Full Text] [Related]
19. Preparation of vancomycin microparticles: importance of preparation parameters.
Hachicha W; Kodjikian L; Fessi H
Int J Pharm; 2006 Nov; 324(2):176-84. PubMed ID: 16876347
[TBL] [Abstract][Full Text] [Related]
20. Surface modification of microspheres with steric stabilizing and cationic polymers for gene delivery.
Davies OR; Head L; Armitage D; Pearson EA; Davies MC; Marlow M; Stolnik S
Langmuir; 2008 Jul; 24(14):7138-46. PubMed ID: 18558783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
